Xiaojing Guo

Dr. Xiaojing Guo

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
XGXiaojing Guo
Xiaojing Guo
HZHaif Haifeng Zhang
Haif Haifeng Zhang
BZBi yu Zeng
Bi yu Zeng
ACAoling Cai
Aoling Cai
JZJunjie Zheng
Junjie Zheng
FWFei Wang
Fei Wang
Background: Early evaluation of treatment efficacy in adolescents and young adults with major depressive episodes (MDEs) remains a clinical challenge, often delaying timely therapeutic adjustments. Electroencephalography (EEG) alpha traveling waves, particularly those elicited by intermittent photic stimulation (IPS), may serve as biomarkers reflecting neural dynamics. This study aimed to investigate whether IPS-induced alpha traveling waves could predict early treatment outcomes in transitional-aged youth with MDEs. Methods: We recorded EEG signals from 119 patients aged 16–24 years at admission, prior to a standardized two-week treatment regimen. IPS was applied using multiple stimulus frequencies, and alpha traveling waves were analyzed in terms of directionality (forward vs. backward) and hemispheric lateralization. Results: Alpha traveling wave amplitudes varied across individuals, depending on stimulus frequency and hemisphere. Notably, a higher amplitude of backward alpha traveling waves at 10 Hz IPS in the left hemisphere significantly predicted positive early treatment response. In contrast, forward waves and right hemisphere responses did not show predictive value. Conclusions: IPS-induced backward alpha traveling waves in the left hemisphere may represent promising EEG biomarkers for early prediction of treatment efficacy in youth with MDEs. These findings offer a potential neurophysiological tool to support personalized treatment strategies and inform future clinical applications in adolescent and young adult depression.

24 April 2025 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
HZHuimin Zhao
Huimin Zhao
QXQinrong Xu
Qinrong Xu
PCPeng Chen
Peng Chen
XGXiaojing Guo
Xiaojing Guo
GWGuanhui Wu
Guanhui Wu
This study aimed to investigate whether late neurological improvement (LNI) during hospitalization serves as a favorable prognostic indicator in patients with acute ischemic stroke (AIS) and to identify the predictors of LNI. We retrospectively analyzed data from the Safe Implementation of Treatments in Stroke (SITS) registry at two stroke centers in Egypt. LNI was defined as the lack of early neurological improvement (ENI) within 24 h after admission, accompanied by neurological improvement within 7 days of hospitalization. Multivariate logistic regression was employed to analyze the factors influencing favorable prognosis (modified Rankin Scale score 0–2) and LNI. A total of 834 patients with AIS were included in this study, of which 130 (15.6%) exhibited LNI. Among these, 99 (76.2%) achieved favorable outcomes. Both ENI (OR = 6.756, 95% CI 3.355–13.603, P < 0.001) and LNI (OR = 5.760, 95% CI 3.146–10.545, P < 0.001) were independently associated with favorable prognosis after adjustment. Predictors of LNI in multivariable-adjusted logistic regression included younger age (OR = 0.973, 95% CI 0.957–0.990, P = 0.001), higher baseline National Institutes of Health Scale (NIHSS) score (OR = 1.196, 95% CI 1.146–1.248, P < 0.001), and rt-PA treatment (OR = 1.953, 95% CI 1.206–3.163, P = 0.006). Approximately three-quarters of patients with LNI are expected to achieve good outcome. LNI was a favorable prognostic indicator in patients with AIS and younger age, higher baseline NIHSS score and rt-PA treatment predicted LNI.

25 August 2026 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
LJLei Jiang
Lei Jiang
WWWenjiang Wu
Wenjiang Wu
LKLinghui Kong
Linghui Kong
JXJiangyun Xiong
Jiangyun Xiong
XZXing Zhang
Xing Zhang
XGXiaojing Guo
Xiaojing Guo
Background: Intracranial and extracranial arteries differ in vascular wall structure and susceptibility to atherosclerosis. However, some patients with acute ischemic stroke have steno-occlusive lesions in both arterial compartments. The factors associated with this cross-compartment distribution remain unclear. We examined whether long-term alcohol consumption was associated with digital subtraction angiography (DSA)-defined concurrent intracranial and extracranial involvement. Methods: This retrospective study included patients with acute ischemic stroke who presented within 7 days of symptom onset and underwent cervicocerebral DSA at Huishui People’s Hospital, Guizhou, China, from January 2024 to March 2026. Long-term alcohol consumption was defined as drinking on at least 3 days per week for at least 5 years before the index stroke. Concurrent involvement was defined as at least one intracranial and at least one extracranial atherosclerotic steno-occlusive lesion in the same patient. The main multivariable logistic regression model included long-term alcohol consumption, age, sex, hypertension, diabetes mellitus, and smoking. Results: Among 249 patients, 59 (23.7%) had long-term alcohol consumption and 126 (50.6%) had concurrent involvement. The prevalence of long-term alcohol consumption was 11.8% in patients with isolated intracranial involvement, 19.1% in those with isolated extracranial involvement, and 32.5% in those with concurrent involvement ( p = 0.003). After adjustment, long-term alcohol consumption remained associated with concurrent involvement (adjusted OR 2.57, 95% CI 1.21–5.50; p = 0.015). Compared with isolated intracranial involvement, long-term alcohol consumption was associated with higher odds of concurrent involvement (adjusted OR 2.73, 95% CI 1.09–6.79; p = 0.031). A similar but nonsignificant estimate was observed when isolated extracranial involvement was the comparator (adjusted OR 2.64, 95% CI 0.94–7.46; p = 0.066). Conclusion: In this DSA-selected cohort, long-term alcohol consumption remained associated with concurrent intracranial and extracranial steno-occlusive involvement after multivariable adjustment. This finding reflects a cross-compartment anatomical distribution pattern rather than overall atherosclerotic burden or stenosis severity. Given the retrospective single-center design, the findings should be interpreted cautiously and confirmed in larger prospective multicenter studies.

31 July 2026 in Medicine
Verified
Journal Article
Open access
WWWenjiang Wu
Wenjiang Wu
JXJiangyun Xiong
Jiangyun Xiong
SYShimei Yin
Shimei Yin
ZCZhiyin Cai
Zhiyin Cai
WWWeili Wang
Weili Wang
XGXiaojing Guo
Xiaojing Guo
Rationale: Graves’ disease (GD) may be associated with ischemic stroke through nonatherosclerotic intracranial arteriopathy during thyrotoxicosis. However, the optimal antithrombotic regimen and treatment duration for this condition remain uncertain. Patient concerns: A 38-year-old man presented approximately 6.5 hours after the last known well with sudden dysarthria, aphasia, and right-sided weakness. His National Institutes of Health Stroke Scale (NIHSS) score was 9 on admission. Diagnoses: Brain magnetic resonance imaging demonstrated acute ischemic infarcts, and magnetic resonance angiography revealed left middle cerebral artery M2 stenosis. In the setting of overt Graves’ thyrotoxicosis and no identified alternative stroke source, the findings supported a diagnosis of Graves’ disease-related reversible intracranial arteriopathy presenting with ischemic stroke. Interventions: The patient received dual antiplatelet therapy with aspirin 100 mg and clopidogrel 75 mg daily for 21 days, together with atorvastatin and antithyroid treatment with thiamazole. The thiamazole dosage was subsequently adjusted according to serial thyroid function tests. Outcomes: The patient’s neurological deficits improved rapidly, and his NIHSS score decreased to 1 at discharge. Biochemical euthyroidism was achieved approximately 5 months after treatment initiation. At 12 months, magnetic resonance angiography demonstrated marked reversal of the left M2 stenosis. At the latest follow-up at 24 months, the patient was neurologically intact and remained free of recurrent ischemic or hemorrhagic events. Lessons: Graves’ disease-related reversible intracranial arteriopathy should be considered in young patients presenting with ischemic stroke, intracranial arterial stenosis, and thyrotoxicosis. This case suggests that short-term dual antiplatelet therapy may be considered as early bridging treatment in selected patients, whereas long-term management should prioritize sustained thyroid control and clinical and vascular imaging follow-up. Further evidence is required to establish the optimal antithrombotic regimen, treatment duration, and criteria for discontinuation.